These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 34732097)

  • 1. The costs of coronavirus vaccines and their pricing.
    Light DW; Lexchin J
    J R Soc Med; 2021 Nov; 114(11):502-504. PubMed ID: 34732097
    [No Abstract]   [Full Text] [Related]  

  • 2. Just allocation of COVID-19 vaccines.
    Herlitz A; Lederman Z; Miller J; Fleurbaey M; Venkatapuram S; Atuire C; Eckenwiler L; Hassoun N
    BMJ Glob Health; 2021 Feb; 6(2):. PubMed ID: 33589419
    [No Abstract]   [Full Text] [Related]  

  • 3. Covid-19: an economic perspective on vaccinating the world.
    Donaldson C; Biosca O
    BMJ; 2021 Jun; 373():n1498. PubMed ID: 34130993
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 vaccines pricing policy options for low-income and middle- income countries.
    Guzman J; Hafner T; Maiga LA; Giedion U
    BMJ Glob Health; 2021 Mar; 6(3):. PubMed ID: 33727281
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID vaccines to reach poorest countries in 2023 - despite recent pledges.
    Padma TV
    Nature; 2021 Jul; 595(7867):342-343. PubMed ID: 34226742
    [No Abstract]   [Full Text] [Related]  

  • 6. Challenges in the rollout of COVID-19 vaccines worldwide.
    Burki TK
    Lancet Respir Med; 2021 Apr; 9(4):e42-e43. PubMed ID: 33684355
    [No Abstract]   [Full Text] [Related]  

  • 7. It's time to consider a patent reprieve for COVID vaccines.
    Nature; 2021 Apr; 592(7852):7. PubMed ID: 33785920
    [No Abstract]   [Full Text] [Related]  

  • 8. Is there light at the end of the Covid-19 tunnel?
    Mortimer PP
    Rev Med Virol; 2021 May; 31(3):e2173. PubMed ID: 33002254
    [No Abstract]   [Full Text] [Related]  

  • 9. The unequal scramble for coronavirus vaccines - by the numbers.
    Callaway E
    Nature; 2020 Aug; 584(7822):506-507. PubMed ID: 32839593
    [No Abstract]   [Full Text] [Related]  

  • 10. Survival of the Wealthiest?
    Garfinkel M; Sansonetti PJ; Pulverer B
    EMBO J; 2020 Dec; 39(23):e107227. PubMed ID: 33205839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why a pioneering plan to distribute COVID vaccines equitably must succeed.
    Nature; 2021 Jan; 589(7841):170. PubMed ID: 33442047
    [No Abstract]   [Full Text] [Related]  

  • 12. Future of covid-19 vaccine pricing: lessons from influenza.
    Ramachandran R; Dhodapkar M; Ross JS; Schwartz JL
    BMJ; 2021 Jun; 373():n1467. PubMed ID: 34158283
    [No Abstract]   [Full Text] [Related]  

  • 13. Incentivising wealthy nations to participate in the COVID-19 Vaccine Global Access Facility (COVAX): a game theory perspective.
    McAdams D; McDade KK; Ogbuoji O; Johnson M; Dixit S; Yamey G
    BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33257418
    [No Abstract]   [Full Text] [Related]  

  • 14. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioethics and practical justice in the post-COVID-19 era.
    Ogbogu U; Hardcastle L
    Dev World Bioeth; 2021 Mar; 21(1):31-35. PubMed ID: 33210409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New WTO leader faces COVID-19 challenges.
    Zarocostas J
    Lancet; 2021 Feb; 397(10276):782. PubMed ID: 33640051
    [No Abstract]   [Full Text] [Related]  

  • 17. Global health and the scientific research agenda.
    Flory JH; Kitcher P
    Philos Public Aff; 2004; 32(1):36-65. PubMed ID: 15658019
    [No Abstract]   [Full Text] [Related]  

  • 18. Pricing increases for cancer drugs sparks investigation.
    Venkatesan P
    Lancet Oncol; 2017 Jul; 18(7):e372. PubMed ID: 28552213
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical pharmaceuticals and distributive justice.
    Boylan M
    Camb Q Healthc Ethics; 2008; 17(1):30-44. PubMed ID: 18462543
    [No Abstract]   [Full Text] [Related]  

  • 20. Don't worry about the drug industry's profits when considering a waiver on covid-19 intellectual property rights.
    Hawksbee L; McKee M; King L
    BMJ; 2022 Jan; 376():e067367. PubMed ID: 35101900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.